# FDA Inspection 1102103 - Teva Pharmaceutical Industries Ltd. - July 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/teva-pharmaceutical-industries-ltd/8a97952c-5a73-4b3f-a122-d58633931305
Source feed: FDA_Inspections

> FDA Inspection 1102103 for Teva Pharmaceutical Industries Ltd. on July 18, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102103
- Company Name: Teva Pharmaceutical Industries Ltd.
- Inspection Date: 2019-07-18
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 995558 - 2016-09-15](https://www.keypedia.com/records/fda_inspections/teva-pharmaceutical-industries-ltd/88586a14-058e-441d-8a19-c87b23684663)
- [FDA Inspection 913214 - 2015-01-08](https://www.keypedia.com/records/fda_inspections/teva-pharmaceutical-industries-ltd/2b40cc70-a2b5-4b0b-b9ea-5a4a22a2cc2e)
- [FDA Inspection 913214 - 2015-01-08](https://www.keypedia.com/records/fda_inspections/teva-pharmaceutical-industries-ltd/c02708a5-c241-4a2a-a23c-7c769c1ca34e)

Company: https://www.keypedia.com/companies/teva-pharmaceutical-industries-ltd/8d962606-fec1-46ca-afc3-14ac64f15c87

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c